AI in clinical trials presents key market opportunities by enhancing patient recruitment, optimizing trial designs, and automating tasks, thus reducing time and costs. Adoption is driven by the need ...
BigBear.ai serves a vital AI niche. Right now, BigBear.ai provides AI applications for government, defense, and security systems. One of its biggest products is TrueFace, an AI-po ...
Teradata (NYSE:TDC) remains a key player in the NYSE Composite, providing innovative data analytics and risk management solutions ...
By Forbes estimates, the elder Ellison, who is also Oracle’s largest shareholder, doesn’t have enough cash on hand to fulfill his part of Paramount’s $111 billion offer for Warner Bros. Discovery.
OpenAI's ( OPENAI) announcement that it has raised $110B in new funding should alleviate the concerns about paying its bills ...
Oracle (NYSE: ORCL) stock is trading down 37% in the last six months and 24% year to date as artificial intelligence (AI) ...
Oracle and Red Bull Racing announced on Thursday a multi-year extension of their data-driven Formula One title partnership and heralded a 'ground-breaking' AI-powered strategy agent for the sport's ...
The world's most valuable company reported better-than-expected fiscal fourth-quarter results after the bell Wednesday ...
Oracle is now down a staggering 54.9% from its all-time high (achieved last September). Here's why Oracle could still be a millionaire maker, and some risks to consider before buying the tech stock.
Tech giants like Microsoft, Amazon and Google may meet Trump to pledge building or buying power for AI data centers to protect U.S.
Unveiling New Strategies for Exadata, Exascale, Out-of-Place Patching, and Post-Quantum Encryption PLANO, TX, UNITED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results